Despite obtaining a complete response with optimal induction therapy, small residual disease often persists, necessitating consolidation therapy to mitigate the risk of relapse by reducing residual illness. In clients who may have obtained seven+three induction therapy, consolidation therapy is initiated with large-dose cytarabine, often called Hi